Patent details

EP2480085 Title: Combination comprising the MEK inhibitor N-{3-Ö3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyridoÖ4,3-dÜpyrimidin-1-ylÜphenyl}acetamide and the Akt inhibitor N-{(1S)-2-amino-1-Ö(3-fluorophenyl)methylÜethyl}-5-chloro-4-(4-chloro-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide

Basic Information

Publication number:
EP2480085
PCT Application Number:
PCT/US/2010/049952
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP108194382
PCT Publication Number:
WO/2011/038085
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Combination comprising the MEK inhibitor N-{3-Ö3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyridoÖ4,3-dÜpyrimidin-1-ylÜphenyl}acetamide and the Akt inhibitor N-{(1S)-2-amino-1-Ö(3-fluorophenyl)methylÜethyl}-5-chloro-4-(4-chloro-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide
French Title of Invention:
Combinaison comprenant l'inhibiteur de MEK N-{3-Ö3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyridoÖ4,3-dÜpyrimidin-1-ylÜphenyl}acetamide et l'inhibiteur d'Akt N-{(1S)-2-amino-1-Ö(3-fluorophényl)-méthylÜ éthyl}-5-chloro-4-(4-chloro-1-méthyl-1H-pyrazole-5-yl )-2-thiophène-carboxamide
German Title of Invention:
Kombination enthaltend den MEK inhibitor N-{3-Ö3-Cyclopropyl-5-(2-fluor-4-iod- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyridoÖ4,3-dÜpyrimidin-1-ylÜphenyl}acetamid und den Akt inhibitor N-{(1S)-2-Amino-1-Ö(3-fluorphenyl)methylÜethyl}-5-chlor-4-(4-chlor-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamid
SPC Number:

Dates

Filing date:
23/09/2010
Grant date:
12/11/2014
EP Publication Date:
12/11/2014
PCT Publication Date:
31/03/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/08/2012
EP B1 Publication Date:
12/11/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/09/2015
Expiration date:
23/09/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/08/2015
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
KUMAR Rakesh
Address:
United States (US)

2

Name:
LAQUERRE Sylvie
Address:
United States (US)

3

Name:
MORRIS Shannon, Renae
Address:
United States (US)

4

Name:
GILMER Tona
Address:
United States (US)

5

Name:
LEBOWITZ Peter, F.
Address:
United States (US)

6

Name:
DUMBLE Melissa
Address:
United States (US)

Priority

Priority Number:
245027 P
Priority Date:
23/09/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A01N 43/54;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages